A Phase 1, Randomized, Open-Label, 3-Period, 3-Treatment, Single-dose Crossover Study to Evaluate the Pharmacokinetic Interaction of LX4211 and Metformin in Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 29 Mar 2011
At a glance
- Drugs Sotagliflozin (Primary) ; Metformin
- Indications Type 2 diabetes mellitus
- Focus Pharmacokinetics
- 29 Mar 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 02 Mar 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 Feb 2011 New trial record